Tops & Flops Stocks
| Security | Change (%) ▼ | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Intersect Ent | 1.500% | - | - | - | - | - | - |
| Carisma Therapeutics Inc. | 1.450% | -3.533% | -20.275% | -87.691% | -47.190% | -96.316% | -97.497% |
| Editas Medicine Inc | 1.420% | -6.098% | -19.835% | -45.681% | -47.527% | -80.834% | -77.532% |
| Regenxbio Inc | 1.310% | 0.000% | -10.405% | -11.429% | -7.186% | -47.617% | - |
| Amphastar Pharmaceuticals Inc | 1.220% | 1.192% | 7.112% | 6.144% | -29.363% | - | - |
| Dynavax Technologies Corp | 1.190% | -6.516% | -10.548% | 0.121% | -22.552% | 53.122% | 40.721% |
| Lantheus Holdings Inc | 1.090% | 0.541% | 26.588% | -21.704% | 25.284% | - | - |
| Fluidigm Corp. | 0.990% | -9.735% | -20.313% | 37.838% | -0.971% | -45.874% | - |
| Travere Therapeutics Inc. | 0.980% | - | - | - | - | - | - |
| Sientra Inc. | 0.940% | - | - | - | - | - | - |
| Cyberoptics Corp. | 0.930% | - | - | - | - | - | - |
| Heska Corp | 0.910% | - | - | - | - | - | - |
| Natural Alternat. | 0.850% | 4.386% | 0.847% | -14.388% | 3.478% | -50.000% | -46.377% |
| Atricure Inc. | 0.850% | - | - | - | - | - | - |
| AnaptysBio Inc | 0.840% | -2.439% | 16.505% | 23.077% | 23.711% | 13.208% | - |
| Ani Pharmaceuticals Inc. | 0.810% | - | - | - | - | - | - |
| Surgery Partners Inc | 0.790% | 11.404% | 4.098% | -22.561% | -11.806% | -38.942% | 179.336% |
| Aspira Womens Health Inc. | 0.750% | -8.844% | -8.844% | -25.556% | -33.827% | -95.663% | -83.518% |
| Anavex Life Sciences Corp | 0.730% | -0.337% | -12.104% | -58.361% | -59.052% | -60.544% | 33.046% |
| Brainstorm Cell | 0.720% | -1.286% | -38.414% | -86.913% | 48.922% | -86.069% | - |
| Kindred Biosciences Inc. | 0.650% | - | - | - | - | - | - |
| Kura Oncology Inc | 0.590% | 0.907% | 3.079% | 83.641% | 47.773% | -8.180% | 25.564% |
| Strongbridge Biopharma plc | 0.590% | - | - | - | - | - | - |
| Harvard Bioscience | 0.580% | -1.149% | -17.703% | -33.204% | -28.033% | -37.455% | 55.868% |
| Chemocentryx Inc. | 0.570% | - | - | - | - | - | - |